HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Olfaction Disorders (Anosmia)

Loss of or impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions.
Also Known As:
Anosmia; Cacosmia; Dysosmia; Cacosmias; Dysosmias; Olfaction Disorder; Paraosmias; Smell Disorder; Paraosmia; Smell Disorders
Networked: 385 relevant articles (13 outcomes, 25 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Sneezing
2. Dysgeusia (Parageusia)
3. Rhinitis
4. Pruritus (Itching)
5. Polyps

Experts

1. Pitteloud, Nelly: 13 articles (09/2015 - 09/2002)
2. Raivio, Taneli: 7 articles (09/2015 - 02/2007)
3. Young, Jacques: 7 articles (09/2015 - 01/2005)
4. Dwyer, Andrew: 7 articles (10/2011 - 09/2002)
5. Crowley, William F: 7 articles (06/2010 - 09/2002)
6. Quinton, Richard: 6 articles (09/2015 - 04/2002)
7. Dodé, Catherine: 6 articles (09/2015 - 01/2005)
8. Hardelin, Jean-Pierre: 6 articles (09/2015 - 01/2005)
9. de Roux, Nicolas: 6 articles (09/2015 - 11/2004)
10. Plummer, Lacey: 5 articles (08/2015 - 02/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Olfaction Disorders:
1. ZincIBA
2. HormonesIBA
09/01/2014 - "Experiments 3-5, which examined sensory regulation of the effect, indicated that olfaction (anosmia), audition (blockade with white noise), and somatosensation (trimming the vibrissae) appear to play little role in the behavioral enhancement observed in the LACTs; Experiment 6 examined the possibility that visual augmentations may facilitate the improvements in predation; testing LACTs in a 0-lux environment eliminated the behavioral advantage (increasing their latencies from -65s to -212s), which suggests that temporary augmentation to the visual system may be important, and with hormone-neural alterations therein a likely candidate for further study. "
05/01/1999 - "A sibship is described where the brother and a sister both have Kallmann's syndrome (anosmia and deficiency of gonadotrophin releasing hormone) and the woman also has streak ovaries. "
09/01/1979 - "Effect of D-leucine-6-luteinizing hormone-releasing hormone ethylamide in patients with hypogonadotropic hypogonadism with anosmia."
11/01/1996 - "Finally the role that genes play on neuronal migration and in guiding the axons to reach their targets have been identified in patients with Kallmann syndrome, a migrational disorder of olfactory axons and hypothalamic gonadotropic hormone-releasing hormone with absent gene at Xp22.3 locus manifested by anosmia and hypogonadotropic hypogonadism."
03/01/2010 - "Congenital hypogonadotropic hypogonadism with anosmia (Kallmann syndrome) or with normal sense of smell is a heterogeneous genetic disorder caused by defects in the synthesis, secretion and action of gonadotrophin-releasing hormone (GnRH). "
3. SteroidsIBA
4. caroverine (P-201)IBA
5. Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
6. Triamcinolone (Aristocort)FDA Link
7. Prednisolone (Predate)FDA LinkGeneric
8. Silver NitrateIBA
9. Methimazole (Thiamazole)FDA LinkGeneric
10. TegafurIBA

Therapies and Procedures

1. Ganglionectomy
2. Surgical Instruments (Clip)
3. Oral Administration
4. Laryngectomy
5. Drug Therapy (Chemotherapy)